We are live on ! Find out more
ACM

Ayer Capital Management Portfolio holdings

AUM $26.8M
This Fund
S&P 500
This Quarter Est. Return
+36.53%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$68.3M
AUM Growth
–
Cap. Flow
+$63.5M
Cap. Flow %
93.05%
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
–
Reduced
–
Closed
–
Avg Time Held
0 quarters
Top 10 Avg Time Held
0 quarters
Top 20 Avg Time Held
0 quarters

Top Buys

Rank Stock Value
1
IOVA icon
Iovance Biotherapeutics
IOVA
+$63.1M
2
CASC
Cascadian Therapeutics, Inc.
CASC
+$409K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
IOVA icon
1
Iovance Biotherapeutics
IOVA
$6.62B
$67.9M 99.4%
+5,604,015
New +$63.1M
2015 Q1
0 quarters
CASC
2
DELISTED
Cascadian Therapeutics, Inc.
CASC
$407K 0.6%
+41,667
New +$409K
2015 Q1
0 quarters

Similar funds

OHCM
Orchard Hill Capital Management New York $22.6M AUM 3.52% 1-Year Est. Return
AC
Altus Capital Mayfield Heights, Ohio $22.6M AUM 34.75% 1-Year Est. Return
IT
Investors Trust Dallas, Texas $32M AUM 1.92% 1-Year Est. Return
WA
Whippoorwill Associates White Plains, New York $19.3M AUM 10.09% 1-Year Est. Return
MCM
Martin Capital Management Elkhart, Indiana $36.5M AUM 4.02% 1-Year Est. Return
ADICC
Abu Dhabi Investment Council Co Abu Dhabi, United Arab Emirates $16.7M AUM 8.06% 1-Year Est. Return
SC
Sumit Capital New York $16.6M AUM 9.66% 1-Year Est. Return
3NC
300 North Capital Pasadena, California $16.3M AUM 27.56% 1-Year Est. Return

Ayer Capital Management's Q1 2015 Portfolio in Review

As of Q1 2015, Ayer Capital Management held 2 positions worth $68.3M. Its ten largest holdings account for 100% of the portfolio.

Ayer Capital Management deployed $63.5M of net new capital in Q1 2015, opening 2 new positions. Its largest new stake was Iovance Biotherapeutics: 5,604,015 shares worth $67.9M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Ayer Capital Management's largest Q1 2015 buy was Iovance Biotherapeutics: 5,604,015 shares worth $67.9M.
  • Ayer Capital Management's ten largest holdings make up 100% of its $68.3M portfolio in Q1 2015.
  • Ayer Capital Management opened 2 new positions and closed 0 in Q1 2015.

Based on Ayer Capital Management's 13F filing for Q1 2015, filed 20 May 2015.